Naproxen, a common non-steroidal anti-inflammatory drug (NSAID), has shown promising antiviral activity against SARS-CoV-2. Beyond inhibiting COX-1 and COX-2 to control inflammation, it binds to the viral nucleoprotein (N), disrupting its RNA-binding and oligomerization essential for replication. Studies in cell models demonstrated that naproxen significantly reduced viral replication and protected bronchial epithelial cells from SARS-CoV-2-induced damage. Its dual-action properties make it a potential therapeutic candidate for COVID-19.
Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.
Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.
Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.